Results 111 to 120 of about 10,988 (206)

Advances towards personalized oncolytic virotherapy for Glioblastoma treatment [PDF]

Glioblastoma (GBM) remains one of the most challenging brain tumors to treat, with limited response to current therapies. This thesis investigates personalized oncolytic virotherapy as a novel approach to treat GBM, focusing on identifying biomarkers for
Stavrakaki, Effie
core   +2 more sources

Precision virotherapy for IDH-mutant astrocytoma. [PDF]

Mol Ther Oncol
Panagioti E, Lawler SE, Yaffe MB, Chiocca EA, Cook CH.   +4 more
europepmc   +1 more source

Emerging and Re-Emerging Viral Pathogens in Oncolytic Virotherapy: A Comprehensive Review. [PDF]

Rev Med Virol
An X, Liu N, Liu J.
europepmc   +1 more source

Advances and Future Expectations in Oncolytic Virus Therapy for Glioblastoma: A Systematic Review of Clinical Trials. [PDF]

Clin Med Insights Oncol
Kenaan N, Bashour G, Kheyrbek N, Haddad S, Sardini M, Sabbagh M, Hannouneh ZA, Ansstas G, Alshehabi Z.   +8 more
europepmc   +1 more source

Allee Effect and Oncolytic Virotherapy: Different Therapeutic Outcomes for Different Tumour Growth. [PDF]

Bull Math Biol
Chen J, Frascoli F, Zhang T.
europepmc   +1 more source

Oncolytic virotherapy counteracts the selection of IFN-unresponsive cancer cells post-immunotherapy but is limited by the emergence of dedifferentiated cancer cells. [PDF]

Front Immunol
Gellert S, Kruse B, Peters J, Bonifatius S, Tüting T, Buzzai AC.   +5 more
europepmc   +1 more source

Intratumoral oncolytic virotherapy in pancreatic cancer: from feasibility to immune priming. [PDF]

Transl Gastroenterol Hepatol
Nishida T, Hayashi Y.
europepmc   +1 more source

Immunobiology of Anticancer Virotherapy With Newcastle Disease Virus in Cancer Patients

, 2017
Virotherapy with oncolytic viruses that preferentially infect and kill cancer cells is a novel and promising strategy for cancer treatment. Newcastle disease virus( NDV), which is pathogenic in birds, has beneficial clinical effects in cancer patients ...
Samad Farashi-Bonab, Nemat Khansari
core  

The interplay between oncolytic viruses, Toll-like receptor signaling, and chemotherapy in overcoming tumor immune tolerance. [PDF]

Front Cell Infect Microbiol
Wu YY, Wu FH, Tseng CY, Chiang PK, Muniri M, Liu HJ.   +5 more
europepmc   +1 more source

Next-generation oncolytic virotherapy for lung cancer: bridging innovative vector engineering with clinical immunotherapy. [PDF]

Transl Lung Cancer Res
Liu J, Zeng R, Li G, Wang J, Xiong A, He X.   +5 more
europepmc   +1 more source